The European Renal Association - European Dialysis and Transplant Association Registry Annual Report 2014: a summary
Status PubMed-not-MEDLINE Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
28584624
PubMed Central
PMC5455253
DOI
10.1093/ckj/sfw135
PII: sfw135
Knihovny.cz E-zdroje
- Klíčová slova
- ESRD, dialysis, epidemiology, kidney transplantation, survival analysis,
- Publikační typ
- časopisecké články MeSH
Background: This article summarizes the European Renal Association - European Dialysis and Transplant Association Registry's 2014 annual report. It describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 2014 within 35 countries. Methods: In 2016, the ERA-EDTA Registry received data on patients who in 2014 where undergoing RRT for ESRD, from 51 national or regional renal registries. Thirty-two registries provided individual patient level data and 19 provided aggregated patient level data. The incidence, prevalence and survival probabilities of these patients were determined. Results: In 2014, 70 953 individuals commenced RRT for ESRD, equating to an overall unadjusted incidence rate of 133 per million population (pmp). The incidence ranged by 10-fold; from 23 pmp in the Ukraine to 237 pmp in Portugal. Of the patients commencing RRT, almost two-thirds were men, over half were aged ≥65 years and a quarter had diabetes mellitus as their primary renal diagnosis. By day 91 of commencing RRT, 81% of patients were receiving haemodialysis. On 31 December 2014, 490 743 individuals were receiving RRT for ESRD, equating to an unadjusted prevalence of 924 pmp. This ranged throughout Europe by more than 10-fold, from 157 pmp in the Ukraine to 1794 pmp in Portugal. In 2014, 19 406 kidney transplantations were performed, equating to an overall unadjusted transplant rate of 36 pmp. Again this varied considerably throughout Europe. For patients commencing RRT during 2005-09, the 5-year-adjusted patient survival probabilities on all RRT modalities was 63.3% (95% confidence interval 63.0-63.6). The expected remaining lifetime of a 20- to 24-year-old patient with ESRD receiving dialysis or living with a kidney transplant was 21.9 and 44.0 years, respectively. This was substantially lower than the 61.8 years of expected remaining lifetime of a 20-year-old patient without ESRD.
Aragon Renal Registry Coordinación de Trasplantes de Aragón Zaragoza Spain
Austrian Dialysis and Transplant Registry Rohr Austria
CHU Tivoli La Louvière Belgium
Department of Internal Medicine Riga Stradins University Riga Latvia
Department of Internal Medicine Tbilisi State Medical University Tbilisi Georgia
Department of Medicine Zealand University Hospital Roskilde Denmark
Department of Nephrology Clinical Centre of Serbia Belgrade Serbia
Department of Nephrology Helsinki University Central Hospital Helsinki Finland
Department of Nephrology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania
Dialysis Clinic 'Alexandrovska' University Hospital Sofia Medical University Sofia Bulgaria
Dienst Nefrologie Jessa Ziekenhuis Campus Virga Jesse Hasselt Belgium
Division of Nephrology Ambroise Paré University Hospital APHP Boulogne Billancourt France
Division of Nephrology Landspitali The National University Hospital of Iceland Reykjavík Iceland
Dutch Renal Registry Nefrovisie Utrecht The Netherlands
Faculty of Medicine School of Health Sciences University of Iceland Reykjavik Iceland
Finnish Registry for Kidney Diseases Helsinki Finland
Information System of Regional Transplant Coordination in Andalucia Andalucia Spain
Lithuanian Nephrology Dialysis and Transplantation Association Kaunas Lithuania
Nephrology and Dialysis Unit AULSS 15 Veneto Italy
Nephrology and Hemodialysis Department Clinical Center of Montenegro Ljubljanska Montenegro
Nephrology Department Nicosia General Hospital Nicosia Cyprus
Public Health Directorate Asturias Spain
Regional Transplant Coordination Office Galicia Spain
Registro de Enfermos Renales de Castilla y León Coordinación de Trasplantes Castilla y León Spain
Registro Español de Enfermos Renales Organización Nacional de Trasplantes Madrid Spain
Registro Madrileño de Enfermos Renales Oficina Regional de Coordinación de Trasplantes Madrid Spain
REIN Registry Agence de la Biomédecine Paris France
Scottish Renal Registry Meridian Court ISD Scotland Glasgow UK
Service of Nephrology UHC 'Mother Teresa' Tirana Albania
Servicio de Nefrología Hospital Universitario Valdecilla Santander Cantabria Spain
Slovak Medical University Bratislava Slovakia
Swedish Renal Registry Department of Medicine Ryhov County Hospital Jonkoping Sweden
Swiss Dialysis Registry Renal Division Stadtspital Waid Zurich Switzerland
UK Renal Registry Learning and Research Southmead Hospital Bristol UK
University Clinic of Nephrology Medical Faculty of Skopje Skopje Macedonia
Zobrazit více v PubMed
ERA-EDTA Registry. ERA-EDTA Registry Annual Report 2014. Amsterdam, The Netherlands: Academic Medical Center, Department of Medical Informatics, 2016
Noordzij M, Kramer A, Abad Diez JM. et al. Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report. Clin Kidney J 2014; 7: 227–238 PubMed PMC
Pippias M, Stel VS, Abad Diez JM. et al. Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report. Clin Kidney J 2015; 8: 248–261 PubMed PMC
Kramer A, Pippias M, Stel VS. et al. Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus. Clin Kidney J 2016; 9: 457–469 PubMed PMC
